Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Globalization Bill Should Focus On “Greatest Risk” Foods – CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Draft legislation to comprehensively reform FDA enforcement and inspection powers should focus more on high-risk foods than on general changes to food safety oversight, according to Stephen Sundlof, director of the agency's Center for Food Safety and Applied Nutrition

You may also be interested in...



Senate Food Safety Bill Continues Congressional Quest To Expand FDA Powers

Senate legislation to reform FDA food safety enforcement has garnered bipartisan and industry support since its introduction July 31, with proposals to boost the agency's authority in the wake of recent concerns about imports and a salmonella outbreak linked to produce

Senate Food Safety Bill Continues Congressional Quest To Expand FDA Powers

Senate legislation to reform FDA food safety enforcement has garnered bipartisan and industry support since its introduction July 31, with proposals to boost the agency's authority in the wake of recent concerns about imports and a salmonella outbreak linked to produce

Senate Food Safety Bill Continues Congressional Quest To Expand FDA Powers

Senate legislation to reform FDA food safety enforcement has garnered bipartisan and industry support since its introduction July 31, with proposals to boost the agency's authority in the wake of recent concerns about imports and a salmonella outbreak linked to produce

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel